Detalhe da pesquisa
1.
The Chronic Effects of a Single Low-Intensity Blast Exposure on Phosphoproteome Networks and Cognitive Function Influenced by Mutant Tau Overexpression.
Int J Mol Sci
; 25(6)2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38542311
2.
A sensitive LC-MS assay using derivatization with boron trifluoride to quantify curcuminoids in biological samples.
Anal Biochem
; 596: 113636, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32081619
3.
Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease.
Neurobiol Dis
; 114: 120-128, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29501530
4.
Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.
J Neurosci
; 34(21): 7124-36, 2014 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24849348
5.
Parallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease.
Neurobiol Dis
; 74: 32-40, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25449907
6.
Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aß pathology and modulates Aß oligomerization.
Neurobiol Dis
; 82: 552-560, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26369878
7.
Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice.
J Biol Chem
; 288(6): 4056-65, 2013 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23264626
8.
Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers.
Brain
; 135(Pt 12): 3735-48, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23183235
9.
[F-18]FDDNP microPET imaging correlates with brain Aß burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aß antibody treatment.
Neurobiol Dis
; 43(3): 565-75, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21605674
10.
11.
Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
J Neurosci
; 29(28): 9078-89, 2009 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19605645
12.
Thinking outside the box about COX-1 in Alzheimer's disease.
Neurobiol Dis
; 38(3): 492-4, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20206264
13.
DHA may prevent age-related dementia.
J Nutr
; 140(4): 869-74, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20181786
14.
Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease.
Nat Neurosci
; 9(2): 234-42, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16415866
15.
The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models.
Front Immunol
; 11: 558036, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33178186
16.
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals.
Neurobiol Dis
; 33(2): 193-206, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19038340
17.
A Novel Model of Mixed Vascular Dementia Incorporating Hypertension in a Rat Model of Alzheimer's Disease.
Front Physiol
; 10: 1269, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31708792
18.
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.
Neuron
; 43(5): 633-45, 2004 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-15339646
19.
Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention.
J Neurosci
; 27(52): 14299-307, 2007 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-18160637
20.
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease.
J Pharmacol Exp Ther
; 326(1): 196-208, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18417733